06.23.25 -- Streamline Your Scale-Up: Key Strategies For Biologics Manufacturing Success

Small-scale downstream studies play a critical role in enabling efficient, low-risk tech transfer by providing data-driven insights that ensure process robustness, support regulatory compliance, and accelerate the transition from development to commercial manufacturing.

One initial requisite for technology transfer is a detailed facility fit assessment and gap analysis, which considers the receiving site manufacturing capabilities, process controls, analytical requirements, material selection, and facility design.

Follow along as Derrick Katayama, Lead Scientist of Formulation Development at Samsung Biologics explores the key challenges faced during biopharmaceutical studies and highlights the latest techniques and innovative solutions that can help overcome these obstacles.